StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock analysis

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Margins

Share of revenue, fiscal years 2010 to 2023

Gross margin

–

Operating margin

-6961.0%−4386.4 pts over 5 years

Net margin

-20395.0%−16941.9 pts over 5 years

See a number that looks wrong?